BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 10671671)

  • 1. 90 Years of progesterone: Ninety years of progesterone: the 'other' ovarian hormone.
    Ali S; Balachandran K; O'Malley B
    J Mol Endocrinol; 2020 Jul; 65(1):E1-E4. PubMed ID: 32580155
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on 'Renewed interest in the progesterone receptor in breast cancer'.
    Simone G; Diotaiuti S; Digennaro M; Sambiasi D; De Summa S; Tommasi S; Altieri R; Mangia A; Dantona C; Paradiso A
    Br J Cancer; 2017 Jul; 117(2):e1. PubMed ID: 28399113
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunohistochemical and Clinicopathological Characteristics of Invasive Breast Carcinoma in Nigeria.
    Wemimo RM; Eziagu UB; Sulaiman OA; Abiodun AE; Idowu NA; Ayinde AA; Taiwo AA
    Oman Med J; 2023 Sep; 38(5):e548. PubMed ID: 38225996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive breast Cancer treatment in Tanzania: landscape assessment to prepare for implementation of standardized treatment guidelines.
    Sood R; Masalu N; Connolly RM; Chao CA; Faustine L; Mbulwa C; Anderson BO; Rositch AF
    BMC Cancer; 2021 May; 21(1):527. PubMed ID: 33971839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor-Defined Breast Cancer in Five East African Countries and Its Implications for Treatment: Systematic Review and Meta-Analysis.
    Popli P; Gutterman EM; Omene C; Ganesan S; Mills D; Marlink R
    JCO Glob Oncol; 2021 Feb; 7():289-301. PubMed ID: 33591798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal Receptors, Human Epidermal Growth Factor Receptor-2 and Triple Negative Immunohistochemical Typing in Women with Breast Cancer in Kampala, Uganda.
    Mlole AT; Yahaya JJ; Othieno E; Kalungi S; Okwi AL
    Int J Womens Health; 2020; 12():1109-1123. PubMed ID: 33343201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating Estrogen Receptor Immunohistochemistry on Cell Blocks From Breast Cancer Patients in a Low-Resource Setting.
    Kimambo AH; Vuhahula EA; Mwakigonja AR; Ljung BM; Zhang L; Van Loon K; Ng DL
    Arch Pathol Lab Med; 2021 Jul; 145(7):834-841. PubMed ID: 33053150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemistry defined subtypes of breast cancer in 678 Sudanese and Eritrean women; hospitals based case series.
    Sengal AT; Haj-Mukhtar NS; Elhaj AM; Bedri S; Kantelhardt EJ; Mohamedani AA
    BMC Cancer; 2017 Dec; 17(1):804. PubMed ID: 29191181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of hormonal receptors and human epidermal growth factor receptor-2 in tissues of women with breast cancer at Muhimbili National Hospital, Dar es salaam, Tanzania.
    Mwakigonja AR; Lushina NE; Mwanga A
    Infect Agent Cancer; 2017; 12():60. PubMed ID: 29142588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular breast cancer subtypes prevalence in an indigenous Sub Saharan African population.
    Galukande M; Wabinga H; Mirembe F; Karamagi C; Asea A
    Pan Afr Med J; 2014; 17():249. PubMed ID: 25309649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triple negative breast cancer in a poor resource setting in North-Western Tanzania: a preliminary study of 52 patients.
    Rambau P; Masalu N; Jackson K; Chalya P; Serra P; Bravaccini S
    BMC Res Notes; 2014 Jun; 7():399. PubMed ID: 24964871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review of breast cancer biology in developing countries (part 1): Africa, the middle East, eastern europe, Mexico, the Caribbean and South america.
    Bhikoo R; Srinivasa S; Yu TC; Moss D; Hill AG
    Cancers (Basel); 2011 May; 3(2):2358-81. PubMed ID: 24212814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference in Risk Factors for Breast Cancer by ER Status in an Indigenous African Population.
    Galukande M; Wabinga H; Mirembe F; Karamagi C; Asea A
    ISRN Oncol; 2013; 2013():463594. PubMed ID: 23936673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer in Kumasi, Ghana.
    Ohene-Yeboah M; Adjei E
    Ghana Med J; 2012 Mar; 46(1):8-13. PubMed ID: 22605883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and epidemiologic profile of breast cancer in Tanzania.
    Burson AM; Soliman AS; Ngoma TA; Mwaiselage J; Ogweyo P; Eissa MS; Dey S; Merajver SD
    Breast Dis; 2010; 31(1):33-41. PubMed ID: 21109721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer burden in central Sudan.
    Elgaili EM; Abuidris DO; Rahman M; Michalek AM; Mohammed SI
    Int J Womens Health; 2010 Aug; 2():77-82. PubMed ID: 21072300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of neoadjuvant chemotherapy on patients with locally advanced breast cancer in a Nigerian semiurban teaching hospital: a single-center descriptive study.
    Arowolo OA; Akinkuolie AA; Lawal OO; Alatise OI; Salako AA; Adisa AO
    World J Surg; 2010 Aug; 34(8):1771-8. PubMed ID: 20467742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of estrogen and progesterone receptors in carcinomas of the female breast in Tanzania.
    Mbonde MP; Amir H; Schwartz-Albiez R; Akslen LA; Kitinya JN
    Oncol Rep; 2000; 7(2):277-83. PubMed ID: 10671671
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.